ABC | Volume 111, Nº6, Dezembro 2018

Minieditorial Helal & Silveira Remodelamento cardíaco em atletas de resistência e de força Arq Bras Cardiol. 2018; 111(6):782-783 1. Silva DV, Waclawovsky G, Kraemer AB, Stein C, Eibel B, Grezzana GB, et al. Comparison of cardiac and vascular parameters in powerlifters and long- distance runners: comparative cross-sectional study. Arq Bras Cardiol. 2018; 111(6):772-781 2. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46(4):690-6. 3. GhaliJK,KadakiaS,CooperRS,LiaoYL.Impactof leftventricularhypertrophy onventriculararrhythmias intheabsenceofcoronaryarterydisease.JAmColl Cardiol. 1991;17(6):1277-82. 4. John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO et al. Ventricular arrhythmias and sudden cardiac death. Lancet. 2012;380(9852):1520-9. 5. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remodelling: clinical significance, diagnostic strategies and implicationsforpreparticipationscreening.BrJSportsMed.2009;43(9):649-56. 6. Morganroth J, Maron BJ, HenryWL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521-4. 7. Lewis EJH, McKillop A, Banks L. The Morganroth hypothesis revisited: enduranceexerciseelicitseccentrichypertrophyoftheheart. JPhysiol.2012; 590(12): 2833–4. 8. Pellicia A, Di Paolo FM, Maron BJ. The athlete’s heart: remodelling, electrocardiogram and preparticipation screening. Cardiol Rev. 2002;10(2):85-90. 9. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P.The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. NEngl J Med. 1991;324(5):295-301. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 783

RkJQdWJsaXNoZXIy MjM4Mjg=